Health
Novel Rapid Lateral Flow Immunoassay Can Function as `Suitcase Laboratory` for On-Site Detection of COVID-19 – HospiMedica
Scientists have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA)…
Scientists have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA) to fulfill the need for rapid and accurate nucleic acid detection at the point of care.The use of the monoclonal antibody S9.6 is the distinctive feature of this process developed by scientists from the Suzhou Institute of Biomedical Engineering and Technology (Suzhou, China). The process recognizes DNA-RNA double-stranded hybrids and enables…
-
Noosa News24 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General21 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General20 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Business22 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock